Galectin Therapeutics (GALT) EBT (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.21% |
| Dec 31, 2025 | 11.71% |
| Sep 30, 2025 | 6.94% |
| Jun 30, 2025 | 33.11% |
| Mar 31, 2025 | 31.72% |
| Dec 31, 2024 | -34.41% |
| Sep 30, 2024 | 16.13% |
| Jun 30, 2024 | -17.51% |
| Mar 31, 2024 | -2.77% |
| Dec 31, 2023 | -3.97% |
| Sep 30, 2023 | -3.50% |
| Jun 30, 2023 | 10.74% |
| Mar 31, 2023 | 1.40% |
| Dec 31, 2022 | -30.31% |
| Sep 30, 2022 | 15.32% |
| Jun 30, 2022 | 2.69% |
| Mar 31, 2022 | -32.01% |
| Dec 31, 2021 | 6.70% |
| Sep 30, 2021 | 0.33% |
| Jun 30, 2021 | -30.59% |
| Mar 31, 2021 | 19.28% |
| Dec 31, 2020 | -32.12% |
| Sep 30, 2020 | 2.80% |
| Jun 30, 2020 | -71.93% |
| Mar 31, 2020 | 30.78% |
| Dec 31, 2019 | -84.52% |
| Sep 30, 2019 | 7.14% |
| Jun 30, 2019 | -26.23% |
| Mar 31, 2019 | 22.13% |
| Dec 31, 2018 | -10.83% |
| Sep 30, 2018 | 28.33% |
| Jun 30, 2018 | 9.82% |
| Mar 31, 2018 | -79.66% |
| Dec 31, 2017 | 46.23% |
| Sep 30, 2017 | 2.22% |
| Jun 30, 2017 | 8.69% |
| Mar 31, 2017 | -7.54% |
| Dec 31, 2016 | -1.44% |
| Sep 30, 2016 | 17.99% |
| Jun 30, 2016 | 18.84% |
| Mar 31, 2016 | -45.58% |
| Dec 31, 2015 | 20.66% |
| Sep 30, 2015 | -26.79% |
| Jun 30, 2015 | 3.79% |
| Mar 31, 2015 | -29.70% |
| Dec 31, 2014 | -7.39% |
| Sep 30, 2014 | -3.06% |
| Jun 30, 2014 | 30.54% |
| Mar 31, 2014 | -72.92% |
| Dec 31, 2013 | 20.98% |
| Sep 30, 2013 | -39.23% |
| Jun 30, 2013 | 20.57% |
| Mar 31, 2013 | -34.81% |
| Dec 31, 2012 | 17.76% |
| Sep 30, 2012 | -8.61% |
| Jun 30, 2012 | -36.41% |
| Mar 31, 2012 | 42.10% |
| Dec 31, 2011 | -66.07% |
| Sep 30, 2011 | 32.11% |
| Jun 30, 2011 | -48.75% |
| Mar 31, 2011 | -56.02% |
| Dec 31, 2010 | -6.45% |
| Sep 30, 2010 | 10.38% |